supp.fit

Vitamin C, Beta-Carotene and Vitamin E: study protocols

84 study groups took Vitamin C together with Beta-Carotene and Vitamin E. These are the doses the studies gave. They are not a recommendation.

Vitamin C: what the research found →

Dose per serving from research: Vitamin C

84 study groups in 61 studies say how much Vitamin C participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mg to 500 mg, 40% of 84 study groups.

Daily doseStudy groups
100 mg or less
5
100 mg to 250 mg
27
250 mg to 500 mg
34
500 mg to 1 g
18

Dose per serving from research: Beta-Carotene

81 study groups in 58 studies say how much Beta-Carotene participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 10 mg to 25 mg, 46% of 81 study groups.

Daily doseStudy groups
5 mg or less
4
5 mg to 10 mg
29
10 mg to 25 mg
37
25 mg to 50 mg
11

Dose per serving from research: Vitamin E

57 study groups in 47 studies say how much Vitamin E participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 25 mg to 50 mg, 21% of 57 study groups.

Daily doseStudy groups
10 mg or less
2
10 mg to 25 mg
9
25 mg to 50 mg
12
50 mg to 100 mg
11
100 mg to 250 mg
6
250 mg to 500 mg
9
500 mg to 1 g
8

Commonly used together

45 of 84 study groups took Vitamin C, Beta-Carotene and Vitamin E with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Zinc
30
Selenium
24
Copper
8
Omega-3 Fatty Acids
3
Vitamin A
3

84 study groups

Study
MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience
1999 · antioxidant vitamin supplement · Men and women aged 40–80 at elevated risk of coronary heart disease death due to prior coronary heart disease, occlusive non-coronary arterial disease, diabetes mellitus, or treated hypertension
250 mg20 mg600 mg5 years—
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
2001 · Antioxidants · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye
500 mg15 mg400 IU8 years—
Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13
2004 · antioxidants alone · Adults aged 55–81 years with age-related macular degeneration categories 1–4 or other AREDS ocular eligibility; participants in AMD categories 2–4 were eligible for this arm, and category 1 participants could also receive antioxidants
500 mg15 mg400 IU339 weeks—
Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35
2013 · Antioxidants · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4)
500 mg15 mg400 IU339 weeks—
No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38
2014 · antioxidants · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years
500 mg15 mg400 IU9 years—
Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial
1997 · vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C was common at baseline
120 mg6 mg15 mg2 years—
"The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants
1999 · antioxidant vitamins and minerals supplementation · Women aged 35 to 60 years and men aged 45 to 60 years, without a stated condition
120 mg6 mg30 mg8 years—
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
2001 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye
500 mg15 mg400 IU8 years—
Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13
2004 · antioxidants plus zinc · Adults aged 55–81 years with AMD categories 2–4 and AREDS ocular eligibility
500 mg15 mg400 IU339 weeks—
The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals
2004 · antioxidant supplement group · French women aged 35–60 and men aged 45–60 in the general population
120 mg6 mg30 mg2739 days—
Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels?
2005 · daily antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years
120 mg6 mg30 mg2739 days—
[The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of antioxidant vitamins and minerals on health]
2006 · antioxidant supplementation · Middle-aged adults in the general population
120 mg6 mg30 mg2738 days—
Antioxidant supplementation increases the risk of skin cancers in women but not in men
2007 · antioxidant group · French adult women and men in a general-population primary-prevention trial
120 mg6 mg30 mg2738 days—
Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study
2010 · antioxidant supplementation · French women aged 35–60 years and men aged 45–60 years
120 mg6 mg30 mg2738 days—
Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35
2013 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4)
500 mg15 mg400 IU339 weeks—
No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38
2014 · antioxidants plus zinc · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years
500 mg15 mg400 IU9 years—
Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial
1997 · combination of trace elements and vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C, zinc and selenium were common at baseline
120 mg6 mg15 mg2 years—
Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants
1998 · active medication · Adults with colorectal polyps; age range and sex not stated
150 mg15 mg75 mg3 years—
Acute effects of ozone on pulmonary function of cyclists receiving antioxidant supplements
1998 · supplementation group · Amateur cyclists; age and sex not reported; no condition stated
650 mg15 mg75 mg90 days12
The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract
2002 · vitamin group · Adult American and English outpatients with early age-related cataract
750 mg18 mg600 mg3 years—
Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone
1998 · supplement group · Mexico City street workers exposed to high ozone levels; age and sex not stated
650 mg15 mg75 mg26 weeks—
[Study of the antioxidant drug "Karinat" in patients with chronic atrophic gastritis]
2004 · Karinat · Patients with chronic multifocal atrophic gastritis
60 mg5 mg10 mg26 weeks34
[Study of an antioxidant dietary supplement "Karinat" in patients with benign breast disease]
2004 · Karinat · Patients with benign breast disease, including mastopathy
60 mg5 mg10 mg26 weeks33
Increased vitamin plasma levels in Swedish military personnel treated with nutrients prior to automatic weapon training
2011 · Nutrients (active treatment) · Normally hearing Swedish military personnel, officers and military academy trainees, ages 18 and older, undergoing weapons training
500 mg18 mg305 mg2 days31
French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial
2011 · antioxidant supplementation · French adults aged 45–60 years enrolled in the SU.VI.MAX study
120 mg6 mg30 mg2922 days—
Combination oral antioxidant supplementation reduces blood pressure
1997 · antioxidants · Hypertensive and normotensive adult outpatients; 21 were attending for hypertension treatment and 17 were normotensive outpatients with minor gastrointestinal complaints.
500 mg30 mg600 mg8 weeks—
Supplementation with antioxidants prior to bone marrow transplantation
1997 · BMT(+) · Bone marrow transplant patients receiving conditioning therapy
450 mg45 mg825 mg3 weeks16
Antioxidants, Helicobacter pylori and stomach cancer in Venezuela
1996 · Treatment 1 · People with precancerous stomach lesions, including chronic gastritis, chronic atrophic gastritis, intestinal metaplasia or dysplasia; age and sex not specified
750 mg18 mg600 mg7 days—
Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network
1996 · V (vitamins) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized
120 mg6 mg15 mg26 weeks—
Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters
1997 · vitamin group · Hospitalized adults older than 65 years; baseline vitamin C deficiency was common
120 mg6 mg15 mg2 years—
Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX
1997 · vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care
120 mg6 mg15 mg1 year—
[Effects of vitamins E, C and beta-carotene on DNA damage]
1999 · trial group · Healthy men aged 50–59 years
100 mg25 mg280 mg20 weeks50
Antioxidant vitamins and low-density-lipoprotein oxidation
1993 · antioxidant supplementation · Adults; ages and health conditions not stated
900 mg18 mg200 mg26 weeks22
Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial
1992 · active treatment · Patients with recurrent non-gallstone pancreatitis
540 mg9,000 IU270 IU10 weeks20
Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study
2014 · softgel half-dose (single softgel) · Healthy adults aged 18–45 years, women and men
226 mg8.6 mg—1 day15
Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study
2014 · softgel full-dose (two softgels) · Healthy adults aged 18–45 years, women and men
452 mg17.2 mg—1 day15
Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study
2014 · tablet full-dose (four tablets) · Healthy adults aged 18–45 years, women and men
452 mg17.2 mg400 mg1 day15
Antioxidant supplementation enhances neutrophil oxidative burst in trained runners following prolonged exercise
2003 · antioxidant vitamin supplement · Healthy trained endurance runners; 6 men and 6 women, mean age 30.1 years
900 mg18 mg90 mg7 days12
Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation
1993 · combined antioxidant therapy · adult male subjects; age and health condition not specified
1 g30 mg800 IU90 days12
Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients
2005 · antioxidant supplementation phase · renal transplant recipients taking cyclosporin A; age and sex not reported
500 mg6 mg400 IU26 weeks10
Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study
2001 · Antioxidant supplementation group · Women aged 35–60 years and men aged 45–60 years in France, general population
120 mg6 mg30 mg2 years—
Diet supplementation with vitamin E, vitamin C and beta-carotene cocktail enhances basal neutrophil antioxidant enzymes in athletes
2002 · antioxidant-supplemented group · Sportsmen; age and health condition not specified
1 g30 mg500 mg90 days—
Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function
2003 · group B [high dose of supplement] · Patients with cystic fibrosis; age and sex not specified
300 mg25 mg200 mg8 weeks—
Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation
2003 · micronutrient supplement group · Alcohol-dependent patients aged 20 to 60 years without severe liver disease, hospitalized for alcohol rehabilitation
120 mg6 mg30 mg3 weeks—
Antioxidant diet supplementation influences blood iron status in endurance athletes
2004 · antioxidant supplemented · Amateur trained male endurance athletes
1 g30 mg500 mg90 days—
Response of blood cell antioxidant enzyme defences to antioxidant diet supplementation and to intense exercise
2006 · antioxidant supplemented · Amateur trained male athletes; age and health condition not specified
1 g30 mg500 mg90 days—
Antioxidant supplementation lowers exercise-induced oxidative stress in young overweight adults
2006 · overweight adults receiving antioxidant treatment · overweight adults aged 18–30 years
500 mg10 mg800 IU8 weeks—
Antioxidant supplementation lowers exercise-induced oxidative stress in young overweight adults
2006 · normal-weight adults receiving antioxidant treatment · normal-weight adults aged 18–30 years
500 mg10 mg800 IU8 weeks—
Multivitamin-mineral supplementation prevents lipid peroxidation during "the Marathon des Sables"
2007 · Supplemented group · Athletes participating in the Marathon des Sables; age and sex not specified
150 mg4.8 mg24 mg4 weeks—
Antioxidant diet supplementation enhances aerobic performance in amateur sportsmen
2007 · antioxidant-supplemented group · Amateur male athletes; age and health condition not stated
1 g30 mg500 mg90 days—
[Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person]
2008 · Group 1 · Adults aged 60–75 years; elderly participants
300 mg16.7 mg200 mg16 weeks—
[Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person]
2008 · Group 2 · Adults aged 60–75 years; elderly participants
300 mg8.4 mg200 mg16 weeks—
[Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person]
2008 · Group 3 · Adults aged 60–75 years; elderly participants
300 mg5.6 mg200 mg16 weeks—
Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults
2009 · Normal-weight antioxidant-treated (N-AOX) · Apparently healthy men and women aged 18–30 years with BMI <25 kg/m²
500 mg10 mg800 IU8 weeks—
Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults
2009 · Overweight antioxidant-treated (O-AOX) · Apparently healthy men and women aged 18–30 years with BMI ≥25 kg/m²
500 mg10 mg800 IU8 weeks—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS antioxidants only · Adults aged 55–80 with early or more advanced age-related macular degeneration
500 mg15 mg400 IU5 years—
Effects of an antioxidant vitamin mixture on lipid peroxidation at rest and postexercise
1993 · antioxidant vitamin group · Young healthy males, mean age 25.0 years
1 g30 mg592 mg6 weeks—
Antioxidants, Helicobacter pylori and stomach cancer in Venezuela
1996 · Treatment 2 · People with precancerous stomach lesions, including chronic gastritis, chronic atrophic gastritis, intestinal metaplasia or dysplasia; age and sex not specified
650 mg15 mg75 mg7 days—
Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network
1996 · VT (vitamins associated with trace elements) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized
120 mg6 mg15 mg26 weeks—
Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease
1997 · mid-dose · Patients with established cardiovascular disease
500 mg12 mg400 IU12 weeks—
Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease
1997 · high dose · Patients with established cardiovascular disease
1 g24 mg800 IU12 weeks—
Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters
1997 · mineral and vitamin group · Hospitalized adults older than 65 years; baseline deficiencies of vitamin C, zinc and selenium were common
120 mg6 mg15 mg2 years—
Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX
1997 · trace elements associated with vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care
120 mg6 mg15 mg1 year—
Effects of supplementation with a combination of antioxidant vitamins and trace elements, at nutritional doses, on biochemical indicators and markers of the antioxidant system in adult subjects
1998 · supplementation group · Adult men aged 45–60 years and women aged 35–60 years
120 mg6 mg30 mg26 weeks—
Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers
1998 · antioxidants without n-3 fatty acids · adult male smokers with hyperlipidaemia
150 mg15 mg75 mg6 weeks—
Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3)
1996 · intervention group · Patients with suspected acute myocardial infarction; age and sex not stated
1 g25 mg400 mg4 weeks63
Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk
2004 · antioxidant-supplemented group · Middle-aged men: myocardial infarction survivors younger than 50 and healthy controls
100 mg6 mg100 mg12 weeks53
[Effect of multiple micronutrients supplementation on anti-oxidative activity and oxidized DNA damage of lymphocytes in children]
2005 · supplement group · Chinese children aged 9–11 years, described as healthy and living in a rural area
300 mg1 mg100 mg8 weeks41
Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status
1991 · antioxidant-supplemented men · Men with low antioxidant status
600 mg27 mg300 mg150 days39
Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled clinical trial
1994 · supplemented group · Healthy men aged 30–58 years who smoked 15–40 cigarettes per day
400 mg30 mg200 mg90 days20
Oxidative stress in humans during work at moderate altitude
1999 · antioxidant mixture group · U.S. Marines engaged in moderate-altitude cold-weather field training; age and sex not reported
500 mg——4 weeks15
Effect of antioxidant supplementation on urine and blood markers of oxidative stress during extended moderate-altitude training
1999 · antioxidant supplement (S) group · US Marine Corps volunteers undergoing 14 days of winter training at approximately 2700 m
500 mg20,000 IU400 IU2 weeks—
Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study
2005 · antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years
120 mg6 mg30 mg2738 days—
Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration
2007 · antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration
500 mg15 mg400 IU2433 days—
Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial
2010 · antioxidant micronutrient combination · Patients with a history of sporadic colorectal adenoma; age and sex not specified
1 g24 mg800 mg120 days—
Effects of 6 weeks of n-3 fatty acids and antioxidant mixture on lipid peroxidation at rest and postexercise
2011 · LCPUFA plus antioxidant mixture · Judoists; age and sex not reported; no diagnosed condition stated
60 mg6 mg30 mg6 weeks—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS antioxidants plus zinc · Adults aged 55–80 with early or more advanced age-related macular degeneration
500 mg15 mg400 IU5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
500 mg15 mg400 IU5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
500 mg15 mg400 IU5 years—
Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants
1997 · antioxidants · male smokers with combined hyperlipidemia
150 mg15 mg75 mg6 weeks—
Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants
1997 · omega-3 FAs and antioxidants · male smokers with combined hyperlipidemia
150 mg15 mg75 mg6 weeks—
Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers
1998 · n-3 fatty acids with antioxidants · adult male smokers with hyperlipidaemia
150 mg15 mg75 mg6 weeks—
Supplementation with antioxidants prior to bone marrow transplantation
1997 · Healthy control group · Healthy controls
450 mg45 mg825 mg3 weeks10
Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration
2007 · antioxidants · Adults aged 55–80 with age-related macular degeneration
500 mg15 mg400 IU2433 days—